본문 바로가기

Land Sale Agreement Signed for Sartorius Biopharmaceutical Raw Materials Facility
  • Date Created : 2022-10-05
  • Number of Views : 54
(221005)싸토리우스 계약 체결(9846)-원본
(221005)싸토리우스 계약 체결(9847)-원본
(221005)싸토리우스 계약 체결(9848)-원본
(221005)싸토리우스 계약 체결(9849)-원본
(221005)싸토리우스 계약 체결(9850)-원본
(221005)싸토리우스 계약 체결(9851)-원본
(221005)싸토리우스 계약 체결(9852)-원본
(221005)싸토리우스 계약 체결(9846)-원본
(221005)싸토리우스 계약 체결(9847)-원본
(221005)싸토리우스 계약 체결(9848)-원본
(221005)싸토리우스 계약 체결(9849)-원본
(221005)싸토리우스 계약 체결(9850)-원본
(221005)싸토리우스 계약 체결(9851)-원본
(221005)싸토리우스 계약 체결(9852)-원본

On October 5, 2022 (Wednesday), the Incheon Free Economic Zone Authority (IFEZ) signed a land sale agreement with Sartorius Korea Operations, a German-affiliated company. Under the agreement, Sartorius plans to construct a research facility for the manufacturing and process development of key raw materials for biopharmaceuticals on an industrial site within the Advanced Industrial Cluster (B) of Songdo International City (211-1 Songdo-dong, covering an area of 24,434 square meters).